The 5th edition of the WHO classification of haemato-lymphoid tumors 2022 acknowledges these similarity relations between the lymphoma entities and segregates DH BCL6 as a subtype of DLBCL, NOS or HGBL, NOS apart from the DH BCL2 (Table 1). This evidence concerns the gene BCL6 and lymphoid neoplasm.